GSK to acquire clinical-stage biopharmaceutical company Affinivax
GSK to acquire clinical-stage biopharmaceutical company Affinivax
Source: directorstalkinterviews.com
Page 13 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hal Barron Today - Breaking & Trending Today
GSK Buys Affinivax for Up to $3.3B in Vaccine Push
The agreement includes an upfront payment of $2.1 billion and two potential development milestones.
Source: themiddlemarket.com
GlaxoSmithKline Acquires US Vaccine Maker For Upto $3.3 Bln
LONDON (dpa-AFX) - British drug company GlaxoSmithKline (GSK.L) will buy Boston-based vaccine developer Affinivax in a deal worth $2.1 billion, as per press releases issued by both the two companies
Source: finanznachrichten.de
Glaxo snaps up US vaccine maker Affinivax in £2.6bn deal
Affinivax is developing a vaccine to combat pneumococcal diseases which include pneumonia and meningitis as well as milder illnesses such as sinusitis.
Source: thisismoney.co.uk